期刊文献+

重组ASP-1蛋白的表达与佐剂活性分析

Expression and adjuvanticity analysis of ASP-1 recombinant protein
下载PDF
导出
摘要 目的:本研究采用基因工程技术表达ASP-1重组蛋白,并对其作剂活性作用进行分析。方法:采用密码子优化合成技术获得大肠杆菌偏性的ASP-1基因,将目的基因克隆至原核表达PQE30载体,转化表达宿主菌进行诱导表达。用纯化的重组表达的ASP-1蛋白作为佐剂,用模式抗原OVA和HIV肽抗原进行进行小鼠免疫试验,分析重组ASP-1蛋白的佐剂活性。结果:通过重叠PCR方法成功合成ASP-1基因,并在大肠杆菌中得到表达。用纯化的重组蛋白为佐剂与模式抗原一起免疫小鼠,同时与用铝佐剂组进行对照研究。试验结果表明,重组ASP-1蛋白可诱导模式抗原产生体液和细胞免疫反应,其佐剂活性高于铝佐剂。结论:重组表达的ASP-1蛋白具有良好的免疫佐剂活性。 Objective: To express the ASP - 1 protein in E. coli and analyze the adjuvanticity of the recombinant protein. Methods : The code - optimized gene of ASP - 1 for E. coli expression was synthesized by assembly PCR and The purified recombinant protein mixed with antigens was used to immunize mice for analysis of the adjuvanticity. Results: Recombinant ASP - 1 protein was expressed successfully in E. coli. The purified and refolded protein was used to immunize mice. Result showed the recombinant ASP - 1 protein may induce both humoral and cell mediated immunity. Conclusion:The recombinant ASP - 1 protein is a potential adjuvant.
出处 《中国卫生检验杂志》 CAS 2008年第7期1245-1248,共4页 Chinese Journal of Health Laboratory Technology
基金 全军医药卫生科研基金资助(06MA336) 国家自然科学基金资助(30471598)
关键词 ASP-1 佐剂 疫苗 免疫应答 ASP - 1 Adjuvant Vaccine Immunity
  • 相关文献

参考文献14

  • 1Erik BL Aluminium adjuvants - in retrospect and prospect [ J ]. Vaccine,2004,22 ( 27 - 28) :3658 - 3668.
  • 2MacDonald AJ, Tawe W, et al. Ov - ASP - 1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti -larva immunity[J]. Parasite Immunol, 2004,26 ( 1 ) :53 - 62.
  • 3Bungener L, Huckriede A, et al. Virosome - mediated delivery of protein antigens in vivo : efficient induction of class I MHC - restricted cytotoxic T lymphocyte activity [J].Vaccine, 2005,23 (10) : 1232 - 1241.
  • 4Pearse M J, Drane D. Iscomatrixr adjuvant for antigen delivery[ J]. Advanced Drug Delivery Reviews, 2005,57 ( 3 ) : 465 - 474.
  • 5Hemmi H, Takeuchi O, et al. A Toll - like receptor recognizes bacterial DNA [ J]. NATURE, 2000,408 ( 6813 ):740 - 745.
  • 6吴超,邹全明.新型疫苗佐剂的研究进展[J].中国生物工程杂志,2005,25(8):10-15. 被引量:9
  • 7McInnes IB, Leung BP, et al. A novel therapeutic approach targeting articular imflammation using the filarial nematode - derived phosphoryl- choline - containing glycoprotein ES - 62 [J]. J Immunol, 2003,171 (4) : 2127 -2133.
  • 8Holland MJ, Harcns YM, et al. Proteins secreted by the parasitic nematode Nippostrongylus brasiliensis act as adjuvants for Th2 responses [J]. Eur J Immunol2000,30 (7): 1977 - 1987.
  • 9MacDonald AJ, Tawe W, et al. Ov - ASP - 1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti - larva immunity [ J ]. Parasite Immunol, 2004,26 ( 1 ) :53 - 62.
  • 10Rouillard JM, Lee W, et al. Gene Oligo : oligonucleotide design for in vitro gene synthesis[ J]. Nucleic Acids Res, 2004,32 ( Web Server issue) :W176 -80.

二级参考文献21

  • 1Marciani D J. Vaccine adjuvant: role and mechanisms of action in vaccine immuogenicty. Drug-Discov-Today, 2003, 8 (20):934-943
  • 2Podda A, Del-Giudice G. MF59-adjuvanted vaccines:increased immunogenicity with an optimal safety profile. Expert Rev Vaccines, 2003, 2(2): 197-203
  • 3Garcon N, Heppner D G, Cohen J. Development of RTS, S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant. Expert Rev Vaccines, 2003,2(2): 231-238
  • 4Aucouturier J, Dupuis L, Deville S, et al. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines. Expert Rev Vaccines, 2002, 1 ( 1 ): 111-118
  • 5Bungener L, Idema J, Ter-Veer W, et al. Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigens. J Liposome Res,2002,12(1-2): 155-163
  • 6Kersten G F, Crommelin D J. Liposomes and ISCOMs.Vaccine,2003, 21(9-10): 915-920
  • 7Guy B, Pascal N, Francon A, et al. Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine. Vaccine,2001, 19(13-14): 1794 - 1805
  • 8Pajak B, Garze V, Davies G, et al. The adjuvant OM-174 induces both the migration and maturation of murine dendritic cells in vivo. Vaccine,2003, 21 (9-10): 836-842
  • 9Lemere C A, Spooner E T, Leverone J F, et al. Intranasal immunotherapy for the treatment of Alzheimer' s disease:Escherichia coli LT and LT (R192G) as mucosal adjuvants.Neurobiol-Aging,2002, 23 (6): 991 - 1000
  • 10Singh A P, Puri S K, Chitnis C E. Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion. Mol Biochem Parasitol,2002,121(1): 21 -31

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部